Skip to content

Reliability and Validity of the French Version of the Virtual Reality Sickness Questionnaire

Reliability and Validity of the French Version of the Virtual Reality Sickness Questionnaire

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06466590
Acronym
VRSQ-F
Enrollment
88
Registered
2024-06-20
Start date
2024-07-01
Completion date
2025-05-14
Last updated
2025-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Virtual Reality Cyber Sickness

Keywords

virtual reality, cyber sickness, assessment

Brief summary

This is a multicenter, controlled, non-randomized interventional clinical study, with minimal risks and constraints, aimed at verifying the reliability of the French version of the VRSQ questionnaire (VRSQ-F) and the validity of the VRSQ-F score by comparing it with the SSQ score.

Interventions

DIAGNOSTIC_TESTUse of Measurement Instrument

Participants will complete the measurement procedure twice, with sessions scheduled one week apart, using the same instrument under standardized conditions. The results from both sessions will be compared to assess the instrument's consistency and accuracy

Sponsors

Pôle Saint Hélier
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

All participants will perform 4 exercises in virtual reality with HMD (Head Mounted Display). Then, they will use the VRSQ-F instrument under study on 2 times separated by 15 minutes. The primary objective is to assess the reliability and validity of this instrument through repeated measures and comparison to SSQ

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

For Healthy people : * Men or women aged 18 to 65 * Person affiliated to a social security scheme * Healthy person with no particular medical condition * Having given their consent to participate in the research For patients : * Men or women aged 18 to 65 * Persons affiliated to a social security scheme * People undergoing regular rehabilitation, walking or in a wheelchair, who can use a virtual reality solution as part of their care. * Having given their consent to take part in the research

Exclusion criteria

* Vestibular and cardiac pathologies, and major visual disorders not compatible with virtual reality rehabilitation * Cognitive and language disorders * Persons under legal protection * Pregnant women * MSSQ greater than 15 * People suffering from photosensitive epilepsy * Persons under the influence of medication that may impair drugs or alcohol * Participant with an implanted medical device that may be affected by radio waves emitted by compatible third-party equipment (e.g. : Pacemaker)

Design outcomes

Primary

MeasureTime frameDescription
Check the validity of the VRSQ-F score by comparing it with the SSQ scoreImmediately after exercisesCriteria validity between SSQ and VRSQ-F. SSQ questionnaire with 16 questions scoring from 0 to 48 VRSQ-F questionnaire with 9 questions from 0 to 27
Reliability of VRSQ-F (Virtual Reality Sickness Questionnaire) using the intraclass correlation coefficient between measurements immediately after VR exercises and 15 min after and Cronbach coefficient of the VRSQ-F questionnaireImmediately after exercisesReliability of VRSQ-F (Virtual Reality Sickness Questionnaire) using the intraclass correlation coefficient between measurements immediately after VR exercises and 15 min after and Cronbach coefficient of the VRSQ-F questionnaire

Secondary

MeasureTime frameDescription
Calculate the minimum detectable change in the questionnaireImmediately after exercisesClinimetric quality: Calculation of the standard error of measurement SEM and the minimum detectable change MDC

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026